IYF iShares U.S. Financials ETF

Expense Ratio
0.38%
Dividend
1.61%
Previous close
$118.40
Est. 12 months change
+18.29%
Projected Price
$140.05

Profitability Metrics

Return on Equity (ROE)
16.71%
Return on Assets (ROA)
4.30%
Return on Invested Capital (ROIC)
21.16%
Weighted Average Cost of Capital (WACC)
6.32%
ROIC - WACC
14.84%
Updated : 2026-04-04 06:05 ET

Valuation Metrics

P/E Ratio
15.20
Forward P/E
13.02
PEG Ratio
1.57
Debt Current Ratio
2.33

Growth & Cash Flow

Gross Margin
62.05%
Operating Margin
34.45%
FCF Margin
31.04%
TTM Revenue Growth
15.54%
Projected 12M EPS Growth
16.73%

Price Change

Price % from 50 SMA
-3.17%
Price % from 200 SMA
-4.48%
6 Months
-5.07%
1 Year
3.83%
2 Years
25.33%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
JPM11.97%
BAC5.06%
WFC4.52%
GS4.47%
C3.69%
MS3.56%
SCHW3.09%
BLK2.83%
SPGI2.51%
CB2.36%

ETF Analysis

Fund Overview

iShares U.S. Financials ETF (IYF) currently reports 141 stock positions (subject to change), placing it in the broadly diversified range by holdings breadth. The top line-up is JPM (11.97%), BAC (5.06%), WFC (4.52%), with JPM as the largest single weight at 11.97%. Together, the top three holdings account for 21.55%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 21.16%, WACC is 6.32%, and the economic spread is 14.84%. On balance, holdings generate meaningful returns above their cost of capital, a hallmark of competitively advantaged businesses. Supporting metrics show ROE at 16.71% and ROA at 4.30%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Turning to how the market is pricing the underlying earnings, trailing P/E of 15.20, forward P/E of 13.02, PEG of 1.57. Trailing and forward valuations are closely aligned, pointing to a market that is pricing continuity rather than improvement in the earnings outlook. A PEG in this range suggests valuation is fair rather than compelling — the portfolio is priced adequately for its growth, with limited buffer for downside revisions. At 2.33, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a portfolio that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.

Margins & Cash Generation

On the margin front: gross margin sits at 62.05%, operating margin at 34.45%, and free cash flow margin at 31.04%. At this gross margin level, the portfolio's holdings demonstrate significant pricing power and production efficiency. The operating margin here is a standout — reflecting businesses that convert a large share of gross profit into operating earnings. At this FCF margin level, the underlying holdings have considerable financial flexibility without reliance on external financing. The margin trifecta here — strong at gross, operating, and free cash flow levels — is a hallmark of competitively advantaged businesses.

Growth & Forward Outlook

The two main inputs to the near-term picture — TTM revenue growth of 15.54% reflecting consistent if unspectacular revenue expansion. Consensus EPS estimates point to 16.7% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue momentum establishes the baseline; analyst price targets reveal how much the market is already paying for future execution on top of that baseline. Delivered returns will ultimately be shaped by the gap — or lack thereof — between operating execution and the expectations embedded in current prices. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The composite picture leans positive, with capital efficiency and growth momentum providing the core of the investment thesis.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.